Catalyst Pharmaceuticals针对Hetero公司关于Firdapse橙皮书专利的诉讼持续进行中

美股速递
Aug 25

Catalyst Pharmaceuticals宣布,该公司针对剩余被告Hetero公司关于Firdapse药品橙皮书所列专利的专利诉讼仍在进行中。这一待决的专利纠纷涉及Firdapse产品在FDA橙皮书中登记的相关专利权益。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10